OHA pauses use of Johnson & Johnson vaccine
Oregon Health Authority (OHA) has asked all of the state’s vaccine providers to immediately stop administering the Johnson & Johnson vaccine due to an announcement released from the U.S. Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) this morning. This is out of an abundance of caution as they review six cases of a rare and severe type of blood clot occurring in women ages 18-48 who have received the Johnson & Johnson vaccine.
What this means for the public:
- If you have received the J&J COVID-19 vaccine and develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination, contact your healthcare provider, or seek medical care.
- Report adverse events following receipt of any COVID-19 vaccine to VAERS
- If you are scheduled to receive the J&J vaccine, please contact your healthcare provider, vaccination location, or clinic to learn about additional vaccine availability.
- FAQ: Oregon Health Authority Immediately Pauses Administering Johnson & Johnson Vaccine
- Watch a recording of OHA media availability
- OHA Press Release
- Video statement from Dr. Paul Cieslak: https://www.youtube.com/watch?v=k2nb8X7nPa4
- Declaración en vídeo del Dr. Emilio DeBess: https://www.youtube.com/watch?v=fcxY6fUgdMg
- Blog: OHA asks the state’s vaccine providers to immediately stop administering the Johnson & Johnson vaccine
- OHA les pide a los proveedores de vacunas del estado que pausen la administración de la vacuna de Johnson & Johnson inmediatamente.